Ampio Pharmaceuticals Inc
OTC:AMPE
Ampio Pharmaceuticals Inc
OTC:AMPE
Price:
0.2912
USD
1.25%
Market Cap:
$332k
Balance Sheet
Balance Sheet Decomposition
Ampio Pharmaceuticals Inc
Ampio Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Ampio Pharmaceuticals Inc
Ampio Pharmaceuticals Inc
Balance Sheet
Ampio Pharmaceuticals Inc
Ampio Pharmaceuticals Inc
Currency: USD
| Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
1
|
11
|
18
|
26
|
50
|
16
|
5
|
8
|
8
|
7
|
17
|
34
|
13
|
4
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
1
|
11
|
18
|
26
|
50
|
16
|
5
|
8
|
8
|
7
|
17
|
34
|
13
|
4
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
13
|
0
|
0
|
0
|
2
|
1
|
2
|
1
|
1
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
1
|
11
|
18
|
26
|
51
|
29
|
5
|
8
|
8
|
8
|
18
|
36
|
13
|
6
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
10
|
9
|
8
|
7
|
6
|
6
|
4
|
3
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
10
|
9
|
8
|
7
|
6
|
6
|
4
|
3
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
5
|
6
|
0
|
0
|
10
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
8
|
8
|
8
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
N/A
|
0
+200%
|
1
+722%
|
19
+2 532%
|
26
+33%
|
36
+39%
|
70
+95%
|
50
-28%
|
14
-73%
|
15
+13%
|
14
-8%
|
14
0%
|
23
+63%
|
39
+70%
|
14
-65%
|
6
-58%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
2
|
1
|
3
|
1
|
4
|
0
|
0
|
0
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
2
|
5
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
5
|
1
|
2
|
2
|
4
|
6
|
2
|
4
|
1
|
4
|
2
|
5
|
1
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
7
|
5
|
46
|
7
|
3
|
4
|
6
|
1
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+300%
|
0
+100%
|
0
+338%
|
5
+1 257%
|
2
-64%
|
2
+17%
|
3
+46%
|
4
+41%
|
13
+223%
|
7
-48%
|
49
+611%
|
9
-82%
|
8
-14%
|
5
-29%
|
12
+115%
|
2
-84%
|
2
+32%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
0
|
2
|
10
|
28
|
40
|
64
|
102
|
134
|
153
|
205
|
171
|
185
|
201
|
218
|
234
|
243
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
1
|
6
|
46
|
64
|
97
|
168
|
171
|
160
|
171
|
176
|
191
|
218
|
245
|
246
|
246
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
-300%
|
0
-575%
|
4
-1 385%
|
18
N/A
|
24
+34%
|
33
+39%
|
66
+100%
|
37
-44%
|
7
-82%
|
34
N/A
|
5
N/A
|
6
+23%
|
18
+172%
|
27
+56%
|
12
-57%
|
3
-72%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
+200%
|
1
+722%
|
19
+2 532%
|
26
+33%
|
36
+39%
|
70
+95%
|
50
-28%
|
14
-73%
|
15
+13%
|
14
-8%
|
14
0%
|
23
+63%
|
39
+70%
|
14
-65%
|
6
-58%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
